VBI Vaccines Inc.

VBI Vaccines Inc. is a global biopharmaceutical company dedicated to improving human health through the development of innovative vaccines and immunotherapies. Their core focus areas are infectious diseases and oncology, with a particular interest in challenging conditions like hepatitis B, COVID-19, and glioblastoma. VBI leverages its proprietary virus-like particle (VLP) technologies, including enveloped VLPs (eVLPs) and mRNA-launched eVLPs (MLEs), to create vaccine candidates that mimic the natural presentation of viruses, stimulating the body's immune system for potent protection and treatment.

VBI is headquartered in Cambridge, Massachusetts, with research and development facilities in Ottawa, Canada, and a research and manufacturing site in Rehovot, Israel. They have a diverse and experienced management team, board of directors, scientific advisory boards, and commercial advisory board, all dedicated to bringing innovative solutions to the prevention and treatment of disease. Their partnerships with other industry leaders, government agencies, and advocacy groups underscore their commitment to collaboration and making a real difference in the world.

VBI Vaccines Inc. offers job flexibility in the form of a proactive and professional work environment with opportunities for career development and advancement. However, the specific level of flexibility offered for each open position is not outlined in the provided job posting.

VBI Vaccines Inc. offers a comprehensive benefits package that includes attractive compensation, an excellent benefits package, comprehensive training programs, a proactive and professional work environment, and career development and advancement opportunities. This includes competitive salaries, health insurance, dental insurance, vision insurance, retirement plans, paid time off, and disability insurance. VBI is committed to fostering a positive and supportive work environment, recognizing that employees are its most valuable asset.

VBI Vaccines Inc. is a global biopharmaceutical company committed to improving human health by stimulating and amplifying the body's immune system to prevent and treat significant infectious diseases and aggressive cancers. Their mission is to leverage their innovative approach to virus-like particles (VLPs), including a proprietary enveloped VLP (eVLP) platform technology and a proprietary mRNA-launched eVLP (MLE) platform technology, to develop vaccine candidates that mimic the natural presentation of viruses, eliciting a potent, natural immune response.

VBI Vaccines Inc. promotes a culture that is driven by a deep commitment to improving human health, fostering a sense of personal responsibility and determination among its employees. The company values collaboration, seeking meaningful partnerships across industries and organizations to tackle the toughest health challenges. This collaborative spirit is coupled with a commitment to diversity, creating an inclusive work environment where innovation and creativity are encouraged.

VBI Vaccines embraces diversity, equity and inclusion as a core value, recognizing that a diverse team strengthens innovation, creativity, and progress. They promote a workplace where all employees are treated with respect and dignity, regardless of background, beliefs, or culture, and they invite individuals to "come as you are" and feel inspired.